Provides accurate, rapid and risk-free measurement of LVEDP
The VeriCor® monitor provides an accurate and non-invasive measurement of left ventricular end-diastolic pressure (LVEDP) that can be easily performed in the doctor’s office or hospital setting. The VeriCor® monitor is useful in the early detection of changes in intravascular volume and may assist the clinician assess and diagnose the presence and severity of heart failure, target treatment, and monitor the effectiveness of medications.
Features:
- The non-invasive VeriCor® monitor received 510(k) clearance from the U.S. FDA.
- The VeriCor® technology is based on the observation that the arterial pressure during the strain phase of the Valsalva maneuver may directly reflect the LVEDP.
- Proprietary algorithm developed from simultaneous LVEDP measurements made in the cardiac catheterization laboratory at the same time testing with the VeriCor® monitor was performed.
Publications: View a list of published abstracts and publications.
 Performing A Test With The
VeriCor® Monitor
The VeriCor® monitor uses a simple breathing maneuver (Valsalva maneuver) during which the arterial pressure is recorded and a series of proprietary algorithms are applied to analyze the resultant changes in the arterial waveform to provide an accurate estimation of LVEDP.
|
